RxDoctor Payments Data

Andrea Uradu, MD

Clinical Cardiac Electrophysiology · Mansfield, OHNPI 1467742502

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (40.1%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 77.8% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $18,887 and has fallen 84.6% since, to $2,913 in 2025.

$46,637in general payments, 2019–2025

Across 282 payments — averaging $165.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$36K
  • Boston Scientific$3K
  • Biosense Webster, Inc.$3K
  • Abbott$2K
  • Medical Device Business Services, Inc.$1K
  • Kestra Medical Technology Services, Inc.$266
  • plus $335 from 7 others

What the payments were for

  • Speaking & faculty fees$16,62736%
  • Grants$1,0582%
  • Travel & lodging$18,71340%
  • Food & beverage$10,00921%
  • Education$2290%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$46,637 in reported general payments places this provider in the 80th percentile of 159 clinical cardiac electrophysiology providers in Ohio.

See all clinical cardiac electrophysiology providers in Ohio

Medicare billing

Part B allowed, 2024
$201,099
Medicare patients
768
Services billed
1,774

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban124$119,501
XareltoRivaroxaban27$30,541
Dofetilide86$16,477
Mexiletine Hcl85$9,021
Flecainide Acetate59$2,842
Amiodarone Hcl159$1,708
Metoprolol Succinate127$1,384
Dabigatran EtexilateDabigatran Etexilate Mesylate11$1,021
Diltiazem 12hr ErDiltiazem Hcl11$1,004
Diltiazem 24hr Er (Cd)Diltiazem Hcl31$769
SotalolSotalol Hcl48$665
Potassium Chloride15$325
Metoprolol Tartrate43$155
Warfarin Sodium13$140
Carvedilol12$119

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Mansfield

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →